127 related articles for article (PubMed ID: 10715411)
1. Graft hyporeactivity induced by donor-derived dendritic cell progenitors.
Hirano A; Fraser MO; Jordan ML; Takayama T; Lu L; Thomson AW
Transplant Proc; 2000 Mar; 32(2):260-4. PubMed ID: 10715411
[No Abstract] [Full Text] [Related]
2. Induction of tolerance-inducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R.
Gorczynski RM; Chen Z; Kai Y; Wong S; Lee L
Transplantation; 2004 Apr; 77(8):1138-44. PubMed ID: 15114074
[TBL] [Abstract][Full Text] [Related]
3. Graft hyporeactivity induced by immature donor-derived dendritic cells.
Hirano A; Luke PP; Specht SM; Fraser MO; Takayama T; Lu L; Hoffman R; Thomson AW; Jordan ML
Transpl Immunol; 2000 Nov; 8(3):161-8. PubMed ID: 11147696
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
5. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo.
Khanna A; Morelli AE; Zhong C; Takayama T; Lu L; Thomson AW
J Immunol; 2000 Feb; 164(3):1346-54. PubMed ID: 10640749
[TBL] [Abstract][Full Text] [Related]
6. [Immune tolerance induced by exosomes derived from regulatory dendritic cells of mice].
Liu YY; Fan HH; Ren YN; Yang J; Nie XX; Zhao LH; Lin JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):406-10. PubMed ID: 18426675
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell progenitors prolong allograft survival through T-helper 2 deviation of the Th1/Th2 paradigm.
Lee WC; Jeng LB; Chiang YJ; Wang HC; Huang CC
Transplant Proc; 2000 Nov; 32(7):2076-7. PubMed ID: 11120074
[No Abstract] [Full Text] [Related]
8. Extension of graft survival with pulsed administration of donor dendritic cells.
Gozzo J; Masli S; De Fazio S
Transplant Proc; 1999; 31(1-2):1196. PubMed ID: 10083534
[No Abstract] [Full Text] [Related]
9. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
10. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
11. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
12. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
14. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture.
De Fazio SR; Monaco AP; Gozzo JJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127
[No Abstract] [Full Text] [Related]
16. Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin.
Aitouche A; Rugeles MT; Zeevi A; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1997 Jun; 29(4):2175-6. PubMed ID: 9193576
[No Abstract] [Full Text] [Related]
17. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
18. Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model.
Chou SH; Chawla A; Lee TH; Zhou Y; Busch MP; Balassanian R; Ferrell L; Cowan MJ
Transplantation; 2001 Dec; 72(11):1768-76. PubMed ID: 11740386
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping and cellular immune responses of cadaveric donor bone marrow cells.
Carreno MR; Esquenazi V; Gomez C; Garcia-Morales R; Mathew J; Cirocco R; Alamo A; Gharagozloo H; Zucker K; Ricordi C; Fuller L; Tzakis A; Miller J
Transplant Proc; 1998 May; 30(3):727-8. PubMed ID: 9595074
[No Abstract] [Full Text] [Related]
20. Expression of dendritic cell markers on bone marrow cells in a fraction enriched for the ability to prolong skin allograft survival in ALS-treated murine recipients.
Masli S; De Fazio SR; Gozzo JJ
Transplant Proc; 1997; 29(1-2):1147-8. PubMed ID: 9123242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
